ArticlePDF Available

A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa

Authors:
  • ATAL BIHARI VAJAPYEE UNIVERSITY BILASPUR CHHATTISGARH

Abstract and Figures

A crucial survival factor for leading pathogen (carrying 40-60% mortality rate) is Tetrahydrodipicolinate NSuccinyltransferase (DAPD EC 2.3.1.117) involves in lysine biosynthesis pathway of P. aeruginosa. Targeting the lysine biosynthesis pathway is a opportunistic and logical site to inhibit the effect of this organism. Withania somnifera, also known as “Indian ginseng”, a reputed herb in ayurvedic medicine, constituting various steroidal lactones (withanolides, withaferins) and saponins which shown various pharmacological activities. We described the docking of 11 secondary metabolites from Withania somnifera into the three dimensional structure of DapD protein of P. aeruginosa using swiss-dock server. Simultaneously, we have checked the ADME values and pharmacokinetics values of these secondary metabolites against the target protein. We have followed the “Lipnski rule of 5” principle and “Molinspiration” tool. Dihydowithaferin, 4-B, Hydroxywithanolide, Withanoloide E, Withanoloide F, Withanoloide D, Withanoloide A) have potential to be used as medicine to treat P.aeruginosa infections. Several known antibiotics also studied along with this approach for comparison purpose.
Content may be subject to copyright.
A Docking Study on Various Secondary Metabolites from
W. somnifera
on
Tetrahydrodipicolinate N-Succinyltransferase Protein Involved in The
Lysine Biosysnthesis Pathway in
P. aeruginosa
Nagwani AK* and Kashyap D
Department of Microbiology & Bioinformatics, University Teaching Department, Bilaspur University, Bilaspur, India
*Corresponding author: Nagwani AK, Department of Microbiology & Bioinformatics, University Teaching Department, Bilaspur University, Bilaspur, India,
Tel: +91-9039950450; E-mail: amitkn52@gmail.com
Received date: June 9, 2018; Accepted date: June 11, 2018; Published date: June 18, 2018
Copyright: © 2018 Nagwani AK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
A crucial survival factor for leading pathogen (carrying 40-60% mortality rate) is Tetrahydrodipicolinate N-
Succinyltransferase (DAPD EC 2.3.1.117) involves in lysine biosynthesis pathway of P. aeruginosa. Targeting the
lysine biosynthesis pathway is a opportunistic and logical site to inhibit the effect of this organism. Withania
somnifera, also known as “Indian ginseng”, a reputed herb in ayurvedic medicine, constituting various steroidal
lactones (withanolides, withaferins) and saponins which shown various pharmacological activities. We described the
docking of 11 secondary metabolites from Withania somnifera into the three dimensional structure of DapD protein
of P. aeruginosa using swiss-dock server. Simultaneously, we have checked the ADME values and
pharmacokinetics values of these secondary metabolites against the target protein. We have followed the “Lipnski
rule of 5” principle and “Molinspiration” tool. Dihydowithaferin, 4-B, Hydroxywithanolide, Withanoloide E,
Withanoloide F, Withanoloide D, Withanoloide A) have potential to be used as medicine to treat P.aeruginosa
infections. Several known antibiotics also studied along with this approach for comparison purpose.
Background/Objectives: Withania somnifera additionally referred to as “Ashwagandha” and “Indian ginseng” is
a medicative plant constituting (isopelletierine, anaferine, cuseohygrine, and anahygrine, etc.), hormone lactones
(withanolides, withaferins) and saponins., P.aeruginosa is a leading gram negative opportunist infectious agent,
carrying a high 40-60% death rate and causes grievous infections in people with compromised immune systems.
Tetrahydrodipicolinate N-Succinyltransferase (DAPD Europetwo.3.1.117) potential targets for brand spanking new
antibacterial drug medication.
Methods/Statistical analysis: The tying up method involves the prediction of matter conformation and
orientation (or posing) inside a targeted binding web site. Swiss Dock may be a tying up internet server. All
calculations are performed on the server aspect, so for tying up run’s don't need any machine power from the user.
The ligands were neutralized and checked for his or her ADME properties victimization computer code
Molinspiration obtainable at machine resources for Drug Discovery (CRDD). The secondary metabolites and
antibiotics were conjointly subjected to Lipinski Rule of 5 value's on server The Supercomputing Facility for
Bioinformatics & machine Biology (SCFBio), Indian Institute of Technology, N. Delhi.
Findings: Among the eleven secondary metabolites from Withania somnifera and seven antibiotics we elect for
docking, Ciproflaxin, Cephalosporin, Tobramycin, and Azlocillin showing the higher result compare to alternative
compounds. Results of ADME properties showed Compounds as 4-B hydroxywithanolide, 2-3 dihydowitaferin A,
Withanoloide E,Withanoloide D, Withanoloide A, and Withanoloide F has higher ADME values then the
unremarkably used antibiotics (Azlocillin, Ciproflaxin, Ticarcillin, and antibiotic). Results of Lipinski rule of five values
are given below in one table. Secondary metabolites like 4-B hydroxywithanolide, 2-3 dihydowitaferin A,
Withanoloide E, Withanoloide D, and Withanoloide F showed higher results for Lipinski rule of five compare to
antibiotics like Alocillin, Mefoxin, Meropenem, and Tobramycin.
Improvements/Applications: Ashwagandha is employed from a few years for several treatments. This analysis
additionally stresses the likelihood of this plant to use for cure of an added chronic infection. The experiment shows
probabilities to develop a brand new drug.
Keywords:
P. aeruginosa
;
W. somnifera
; Tetrahydrodipicolinate N-
Succinyltransferase; Swiss dock; Lysine biosynthesis pathway
Introduction
P. aeruginosa
is associate expedient human infectious agent. It’s an
expedient as a result of it cause infection to healthy people. Instead, it
typically aects immune-compromised patients, like those with
monogenic disorder, cancer, or AIDS.
P. aeruginosa
may be a leading
gram-negative expedient infectious agent and, carrying a 40-60% rate.
M
o
l
e
c
u
l
a
r
B
i
o
l
o
g
y
:
O
p
e
n
A
c
c
e
s
s
ISSN: 2168-9547
Molecular Biology : Open Access Nagwani and Kashyap, Mol Bio 2018, 7:3
DOI: 10.4172/2168-9547.1000214
Research Article Open Access
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
It complicates ninetieth of pancreatic brosis death, and lastly, it's
invariably listed joined of the highest 3 most frequent gram-negative
pathogens everywhere world [1].
P. aeruginosa
conjointly carries a
great deal of chromosome-mobilizing plasmids that a terribly vital to
the organisms way as a microorganism [2].
P. aeruginosa
attacks mucoviscidosis patients
via
airway and once
it's in, it uses its agellum for visit the hypoxic zone, associate degree
oxygen depleted atmosphere. is can be the transition state for
P.
aeruginosa
undergoes for associate degree aerobic to associate degree
anaerobic microorganism and starts forming biolms anaerobically.
Once this can be fashioned, the
P. aeruginosa
will sense their
population
via
gathering sensing, wherever they secret low mass
pheromones that change them to speak with one another at intervals a
community [3,4]. is oers them the a resistance to several defenses,
as well as anti-Pseudomonas antibiotics like ticarcillin, Mefoxin,
tobramycin, and antibiotic, as a result of once the bacterium sense that
their outer layer of biolm is being destroyed, the inner layers can
grow a lot of powerfully to alter the community [5].
Randomized transpo-son mutagenesis screens had indicated several
genes from the diaminopimelate (DAP) biosynthetic pathway to lysine
in
P. aeruginosa
as essential, suggesting that this gene products as
potential targets for new antibacterial drugs.
P. aeruginosa
mutants
where the dap A sequence had been deleted were viable and able to
grow throughout a mouse internal organ infection model, suggesting
that Dap A is not associate best target for drug development against
this organism [6].
Plants are made during a wide selection of secondary metabolites
like tannins, terpenoids, alkaloids, avonoids etc. that are found to
own antimicrobial properties.
Withania somnifera
(L) Dunal
(Aswaghanda or Indian “Ginseng”) is wide employed in ayurvedic
medicines and is consumed as a dietary supplement round the world.
e major bioactive compounds of Ashwagandha are steroidal lactones
compounds referred to as withanolides. ey conjointly contain many
alkaloids, withanosides, reducing sugars, few avonoids, tannins etc.
[7].
ere are several novel structural variants of withanolides with
modications either of the chemical element skeleton or the
aspectchain and these have typically been delineate as changed
withanolides or ergostan-type steroids associated with withanolides.
Hence, the current study was aimed to spot the potential Dap D
inhibitors from
W. somnifera
by molecular arrival studies exploitation
Swiss Dock net server [8,9].
Materials and Methods
Selection of docking molecules
e SDF (SQL Server Compact info File) les of eleven varied
chemicals (secondary metabolites) has been downloaded from
Pubchem info of NCBI. For the docking studies. Equally the
commercially oered medicine specically antibiotics like Azlocillin,
Ciproaxin, Levooxocin, Meropenem, Ticarcillin and antibiotic were
taken from the literature.
e ligands were neutralized and checked for their ADME
properties mistreatment code Molinspiration on the market at
machine resources for Drug Discovery (CRDD) (http://
www.molinspiration.com/cgi-bin/properties). It helps in analyzing the
pharmacological medicine and pharmacodynamics of the matter by
assessing the drug like properties.
e secondary metabolites and antibiotics were additionally
subjected to Lipinski Rule of 5 values on server e Supercomputing
Facility for Bioinformatics & machine Biology (SCFBio), Indian
Institute of Technology, N. Delhi. Lipinski rule of ve helps in
characteristic between drug like and non-drug like molecules. It
predicts high likelihood of success or failure because of drug likeness
for molecules compliant with a pair of or a lot of rules [10,11].
Target protein
Tetrahydrodipicolinate N-Succinyltransferase (DAPD European
Economic Community two.3.1.117) could be a succinyl-coenzyme A
(SCoA) dependant accelerator. Dap D shows distinct options at the N
and C terminal domains that area unit structurally completely dierent
from those delineated for Dap D enzymes from gram-negative
microorganism and shows additional similarity to Dap Ds from M.
T.B. e sequence/structure of Dap D super molecule is downloaded
from Protein data Bank (PDB ID-3R5A, B, C) As shown in Figure 1.
Figure 1: 3D structure of
P. seudomonas aeruginos
a Dap D
(PA3666) in complex with CoA and succinate.
Docking
Docking was applied victimisation Swiss Dock internet server [12].
e structure of the target super molecule, similarly as that of the
matter, is oen mechanically ready for arrival. Additionally, the
cumbersome syntax of the arrival engine is hidden behind a clean
internet interface providing cheap various sets of parameters similarly
as sample input les. All calculations area unit performed on the server
aspect, so arrival runs don't need any machine power from the user.
e interpretation of arrival results and their integration into existing
analysis pipelines is greatly expedited by the seamless image of arrival
predictions within the UCSF Chimera molecular viewer, which might
be launched directly from the online browser. e sequence code
3R5A, B, C was used for arrival purpose.
Citation: Nagwani AK and Kashya D (2018) A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-
Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa. Mol Bio 7: 214. doi:
10.4172/2168-9547.1000214
Page 2 of 6
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
Structure of 3R5A, B, C was submitted to Swiss Dock sever. e
series (3R5A) has been used for Swiss Dock that is predicated on
EADock DSS with anoloides and dierent compounds (from
W.
somnifera
) were uploaded for docking.
e Predicted les from Swiss Dock server were analyzed
exploitation UCSF Chimera. UCSF Chimera may be an extremely
protractible program for interactive mental image and analysis of
molecular structures [13]. Discovery Studio beholder version four, 2
were used for mental image of docked ligands. We have a tendency to
were used PyMOL for analysis of docking results. e code free for
academic and analysis purpose [14]. VEGA ZZ was used for format
conversion and mental image of compounds and docking results
[15-17] as shown in Figure 2.
Figure 2a: With anoloide E with Tetrahydrodipicolinate N-
Succinyltransferase viewed in UCSF Chimer.
Figure 2b: With anolide F with Tetrahydrodipicolinate N-
Succinyltransferase viewed in UCSF Chimera.
Figure 2c: 4-B, hydroxywithanoloide E with Tetrahydrodipicolinate
N-Succinyltransferases viewed in UCSF Chimera.
Figure 2d: 2-3dihydrowithaferin with Tetrahydrodipicolinate N-
Succinyltransferase viewed in UCSF Chimer
Figures 2a, 2b, 2c and 2d show the best docking interaction of target
protein and some secondary metabolites [18-21].
Results
We took eleven secondary metabolites from Withania
somnifera and seven antibiotics for docking study.
e docking conrmation with best docking Score had been analyzed.
e results obtained from Swiss-Dock
were analyzed mistreatment UCSF Chimera. Swiss-Dock
results are given in terms of full tness and ΔG Kcal/mol. e number
of hydrogen bond found between the target super molecule and also
the secondary metabolites ranged 1- 3.
Binding mode of available drug molecules
For comparison purpose, a bunch of antibiotics were extensively
utilized for tying up with target macromolecule. square measure able
to analyze that and therefore the results are, Ciproaxin, antibiotic
drug, Tobramycin, and Azlocillin showing sensible interaction in terms
Citation: Nagwani AK and Kashya D (2018) A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-
Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa. Mol Bio 7: 214. doi:
10.4172/2168-9547.1000214
Page 3 of 6
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
of ΔG and nearly all are having sensible binding interactions as shown
in Table 1.
S.no. Antibiotics Energy Simple fitness Full fitness Cluster Rank No. of Hydrogen Bond
1 Azlocillin 110.05 110.05 -1565 0 3
2 Cephalosporin 130.33 130.33 -1484.5 2 1
3 Ciproflaxcin 266.25 266.25 -1382.5 7 2
4 Levoflaxcin 62.47 62.47 -1565 7 1
5 Meropenem 107.12 107.12 -1548.7 5 2
6 Ticarcillin 96.91 96.91 -1564.2 7 2
7 Tobramycin 113.73 113.73 -1525.1 4 3
Table 1: Antibiotics with their docking results.
Binding mode of bioactive compounds from
W. somnifera
Aer analysis of result, we will clearly observe that, aer we have
taken full tness as criteria, we tend to area unit able to found
Scopoletin, Cuscohygrine, Tropine, Cysteine showing high binding
anity to the target macromolecule. Once the results of docking were
analyzed using ΔG as criteria, 4-B hydroxywithanolide, 2-3
dihydowitaferin A, Withanoloide E, Withanoloide D, Withanoloide A,
showed high anity to focus on macromolecule as shown in Table 2.
S.no. Compounds Energy Simple
fitness Full fitness Cluster Rank No. of Hydrogen Bond
1 Dihydowithaferin 274.27 274.27 -1334.1 7 1
2 4-B, Hydroxywithanolide 284.92 284.92 -1320.7 4 2
3 Withanoloide E 313.8 313.8 -1285.9 16 2
4 Withanoloide F 83.49 83.49 -1501.9 22 3
5 Withanoloide D 339.55 339.55 -1253.7 5 2
6 Withanoloide A 266.67 266.67 -1363.4 4 1
7 Choline 77.34 77.34 -1580.3 1 1
8 Tropine 34.67 34.67 -1597.7 7 2
9 Cuscohygrine -5.71 -5.71 -1682.9 4 1
10 cysteine 1.45 1.45 -1626.8 3 3
11 scopoletin 1.66 1.66 -1618.7 38 2
Table 2: Compounds with their docking results.
Results of ADME properties
It showed Compounds as 4-B hydroxywithanolide, 2-3
dihydowitaferin A , Withanoloide E, Withanoloide D, Withanoloide A,
and Withanoloide F has higher ADME values then the normally used
antibiotics (Azlocillin, Ciproaxin, Ticarcillin, and Tobramycin) as
shown in Table 3.
S.no. Compounds MiLogP TPSA MW Antibiotics MiLogP TPSA MW
1 Dihydowithaferin 3.88 96.36 472.62 Azlocillin 0.99 148.14 461.5
2 4-B, Hydroxywithanolide 2.26 136.82 502.6 Ticarcillin 0.44 124 384.44
3 Withanoloide E 3.18 116.59 486.61 Tobramycin -5.7 268.19 467.52
Citation: Nagwani AK and Kashya D (2018) A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-
Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa. Mol Bio 7: 214. doi:
10.4172/2168-9547.1000214
Page 4 of 6
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
4 Withanoloide F 3.75 104.06 470.61 Ciproflaxin -0.7 74.57 331.35
5 Withanoloide D 4.15 96.36 470.61
6 Withanoloide A 4.15 96.36 470.61
Table 3: Comparison of ADME values.
Results of Lipinski rule of 5
Values given in Table no. 4. Secondary metabolites like 4-B
hydroxywithanolide, 2-3 dihydowitaferin A, Withanoloide E,
Withanoloide D, and Withanoloide F showed higher results for
Lipinski rule of ve compare to antibiotics like Alocillin, Meropenem,
and Antibiotic drug as shown in Table 4.
S.no. Compounds
Molecular
Weight
High
Liphophicity
Molar
Refractivity
Antibiotics Molecular
Weight
High
Liphophicity
Molar
Refractivity
(130.0 to
725.0) (-2 to 6.5) (40-130)
1 Dihydowithaferin 472 3.58 124.56 Azlocillin 460 3 110.85
2 4-B, Hydroxywithanoloide 502 1.73 127.43 Cephalosporin 385 4 84.92
3 Withanoloide E 486 2.75 126.04 Meropenem 383 3 92.27
4 Withanoloide F 470 3.54 126.52 Tobramycin 472 3 101.87
5 Withanoloide D 470 3.5 124.51
6 Withanoloide A 470 3.5
Table 4: Comparison of Lipinski rule of 5 values.
Discussion
Interactions of secondary metabolites and antibiotics at the active
site of Dap D. e two adjacent subunits that kind a lively website cle
however distinct from the binding sites for CoA and succinate. We
found result in form of full tness and ΔG Kcal/mol are reliable
because it is additionally not showing results once there's no suitability
of chemical with target super molecule for binding, whereas with Swiss
dock, whenever results were obtained in terms of full tness. ere
wasn't one case, aer we didn't get results.
Conclusion
All the work done here recommend that the compounds beneath
study (Dihydowithaferin, 4-B, Hydroxywithanolide, Withanoloide E,
Withanoloide F, Withanoloide D, Withanoloide A ) have potential to be
used as drugs to treat
P. aeruginosa
infections in humans.
Acknowledgement
e entire work done by me under the guidance of my professor Mr.
Dharmendra Kashyap and that I am therefore appreciative to him. All
the soware’s and internet tools square measure used from
Bioinformatics laboratory of University Teaching Department,
Bilaspur University. I am therefore appreciative to my family and
friends for their support
References
1. Bhawsar NA, Singh M (2014) Isolation and characterization of
Pseudomonas aeruginosa from waste soybean oil as biosurfactants which
enhances biodegradation of industrial waste with special reference to
kosmi dam, betul district, (M.P.). Int J Adv Res 2: 778-783.
2. Raj LM, Kalaigandhi V, Kanagaraj C (2015) e occurrence of (MDR/
MDS) Pseudomonas aeruginosa among nosocomial and community
acquired infections in and around coimbatore, India. Int J Curr Microbiol
App Sci 4:753-761.
3. Palamthodi SM, Gaikwad VJ, Ghasghase NV, Patil SS (2011) Antibacterial
targets in Pseudomonas aeruginosa. Int J Appl Pharm Biol Res 2: 159-164.
4. Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring
in virtual screening for drug discovery: Methods and application. Nat Rev
Drug Discov 3: 935.
5. Smiley A, Hassett D (2010) Pseudomonas aeruginosa biolm infections
in cystic brosis, biolms, infection, and antimicrobial therapy. Future
Microbiol 5: 1663-1674.
6. Schnell R, Oehlmann W, Sandalova T, Braun Y, Huck C, et al. (2012)
Tetrahydrodipicolinate N-Succinyltransferase and dihydrodipicolinate
synthase from Pseudomonas aeruginosa: Structure analysis and gene
deletion. PLoS One 7: e311.
7. Santhi N, Aishwarya S, (2010) Insights from the molecular docking of
with anolide derivatives to the target protein PknG from Mycobacterium
tuberculosis. Bioinformation 7: 1-4.
8. Meng XY, Zhang HX, Mezei M, Cui C (2011) Molecular docking: A
powerful approach for structure-based drug discovery. Curr Comput
Aided Drug Des 7:146-157.
9. Elliotatn TSJ, Greenwood DD (1983) e response of Pseudomonas
aeruginosa to azlocillin, ticarcillin and cefsulodin. J Med Microblol 16:
351-362.
10. Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial- resistant
pseudomonas aeruginosa: Clinical impact and complex regulation of
chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:
582-610.
Citation: Nagwani AK and Kashya D (2018) A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-
Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa. Mol Bio 7: 214. doi:
10.4172/2168-9547.1000214
Page 5 of 6
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
11. Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small
molecule docking web service based on EADock DSS. Nucleic Acids Res
39.
12. SwissDock, a protein-small molecule docking web service based on
EADock DSS.
13. UCSF Chimera: An extensible molecular modeling system
14. View 3D Molecular Structures. Pymol.
15. Molecular Modeling Toolkit, Drug Design Laboratory.
16. Oberhardt MA, Puchalka J, Fryer KE, Martins dos Santos VA, Papin JA
(2008) Genome-Scale Metabolic Network Analysis of the Opportunistic
Pathogen Pseudomonas aeruginosa PAO1. J Bacteriol 8: 2790-2803.
17. Hancock RE, Speert DP (2000) Antibiotic resistance in Pseudomonas
aeruginosa: mechanisms and impact on treatment. Drug Resist Updat 3:
247-255.
18. Gfeller D, et al. (2014) SwissTarget Prediction: a web server for target
prediction of bioactive small molecules. Nucleic Acids Res 42: 32-38.
19. Davis L, Kuttan G (2000) Immunomodulatory activity of Withania
somnifera. J Ethnopharmacol 71: 193-200.
20. Velasco AM, Leguina JI, Lazcano A (2002) Molecular Evolution of the
Lysine Biosynthetic Pathways. J Mol Evol 55: 445-449.
21. Hutton CA, Perugini AM, Gerrard AJ (2007) Inhibition of lysine
biosynthesis: an evolving antibiotic strategy. Mol BioSyst 3: 458-465.
Citation: Nagwani AK and Kashya D (2018) A Docking Study on Various Secondary Metabolites from W. somnifera on Tetrahydrodipicolinate N-
Succinyltransferase Protein Involved in The Lysine Biosysnthesis Pathway in P. aeruginosa. Mol Bio 7: 214. doi:
10.4172/2168-9547.1000214
Page 6 of 6
Mol Bio, an open access journal
ISSN:2168-9547
Volume 7 • Issue 3 • 1000212
... Acyclic inhibitors like compounds 33 and 34 are more potent inhibitors compared to the cyclic substrate analogs [201]. In recent years, docking-based studies on P. aeruginosa along with validation from Lipinski's rule and ADME properties, have come up with new inhibitors like withanolide E (compound 35), dihydrowithaferin, and hydroxywithanolide [202]. ...
Article
Background: Antimicrobial resistance is a global health issue that requires immediate attention in terms of new antibiotics and new antibiotic targets. The l-lysine biosynthesis pathway (LBP) is a promising avenue for drug discovery as it is essential for bacterial growth and survival and is not required by human beings. Scope of review: The LBP involves a coordinated action of fourteen different enzymes distributed over four distinct sub-pathways. The enzymes involved in this pathway belong to different classes, such as aspartokinase, dehydrogenase, aminotransferase, epimerase, etc. This review provides a comprehensive account of the secondary and tertiary structure, conformational dynamics, active site architecture, mechanism of catalytic action, and inhibitors of all enzymes involved in LBP of different bacterial species. Major conclusions: LBP offers a wide scope for novel antibiotic targets. The enzymology of a majority of the LBP enzymes is well understood, although these enzymes are less widely studied in the critical pathogens (according to the 2017 WHO report) that require immediate attention. In particular, the enzymes in the acetylase pathway, DapAT, DapDH, and Aspartokinase in critical pathogens have received little attention. High throughput screening for inhibitor design against the enzymes of lysine biosynthetic pathway is rather limited, both in number and in the extent of success. General significance: This review can serve as a guide for the enzymology of LBP and help in identifying new drug targets and designing potential inhibitors.
Article
Full-text available
Moringa oleifera Lam (Moringaceae) is a nutritionally and medicinally significant plant. It is a tropical and subtropical plant that originated in India and is now widely scattered around the world. Its various components provide protein, vitamins, and minerals, as well as medicinal and biotechnological possibilities. Moringa oleifera (Moringa pterygosperma Gaertn) is a medicinal plant that contains phytochemicals that acts as an antiatherosclerotic, anti-inflammatory, anticancer, antimicrobial, antioxidant, hepatoprotective, hypocholesterolemic, hypoglycemic, hypolipidaemic, immunomodulatory, nephroprotective, neuroprotective, and antitumor agents. A powerful molecule must reach its target in the body in sufficient concentration and stay there in a bioactive form long enough for the predicted biologic activities to occur for it to be effective as a medication. The goal of this study was to determine bioavailability potential of phytocompounds established in M. oleifera plant sections using absorption, distribution, metabolism, and excretion (ADME). The SwissADME online tool was used to do an insilico analysis, specifically pharmacokinetics, bioavailability, drug-likeness, and medicinal chemistry friendliness prediction, in order to determine the lead phytocompound for the cancer treatment drug candidate.
Article
Full-text available
Bioactive small molecules, such as drugs or metabolites, bind to proteins or other macro-molecular targets to modulate their activity, which in turn results in the observed phenotypic effects. For this reason, mapping the targets of bioactive small molecules is a key step toward unraveling the molecular mechanisms underlying their bioactivity and predicting potential side effects or cross-reactivity. Recently, large datasets of protein–small molecule interactions have become available, providing a unique source of information for the development of knowledge-based approaches to computationally identify new targets for uncharacterized molecules or secondary targets for known molecules. Here, we introduce SwissTargetPrediction, a web server to accurately predict the targets of bioactive molecules based on a combination of 2D and 3D similarity measures with known ligands. Predictions can be carried out in five different organisms, and mapping predictions by homology within and between different species is enabled for close paralogs and orthologs. SwissTargetPrediction is accessible free of charge and without login requirement at http://www.swisstargetprediction.ch.
Article
Full-text available
The diaminopimelic acid pathway of lysine biosynthesis has been suggested to provide attractive targets for the development of novel antibacterial drugs. Here we report the characterization of two enzymes from this pathway in the human pathogen Pseudomonas aeruginosa, utilizing structural biology, biochemistry and genetics. We show that tetrahydrodipicolinate N-succinyltransferase (DapD) from P. aeruginosa is specific for the L-stereoisomer of the amino substrate L-2-aminopimelate, and its D-enantiomer acts as a weak inhibitor. The crystal structures of this enzyme with L-2-aminopimelate and D-2-aminopimelate, respectively, reveal that both compounds bind at the same site of the enzyme. Comparison of the binding interactions of these ligands in the enzyme active site suggests misalignment of the amino group of D-2-aminopimelate for nucleophilic attack on the succinate moiety of the co-substrate succinyl-CoA as the structural basis of specificity and inhibition. P. aeruginosa mutants where the dapA gene had been deleted were viable and able to grow in a mouse lung infection model, suggesting that DapA is not an optimal target for drug development against this organism. Structure-based sequence alignments, based on the DapA crystal structure determined to 1.6 Å resolution revealed the presence of two homologues, PA0223 and PA4188, in P. aeruginosa that could substitute for DapA in the P. aeruginosa PAO1ΔdapA mutant. In vitro experiments using recombinant PA0223 protein could however not detect any DapA activity.
Article
Full-text available
A crucial virulence factor for intracellular Mycobacterium tuberculosis survival is Protein kinase G (PknG), a eukaryotic-like serinethreonine protein kinase expressed by pathogenic mycobacteria that blocks the intracellular degradation of mycobacteria in lysosomes. Inhibition of PknG results in mycobacterial transfer to lysosomes. Withania somnifera, a reputed herb in ayurvedic medicine, comprises a large number of steroidal lactones known as withanolides which show various pharmacological activities. We describe the docking of 26 withanferin and 14 withanolides from Withania somnifera into the three dimensional structure of PknG of M. tuberculosis using GLIDE. The inhibitor binding positions and affinity were evaluated using scoring functions- Glidescore. The withanolide E, F and D and Withaferin - diacetate 2 phenoxy ethyl carbonate were identified as potential inhibitors of PknG. The available drug molecules and the ligand AX20017 showed hydrogen bond interaction with the aminoacid residues Glu233 and Val235. In addition to Val235 the other amino acids, Gly237, Gln238 and Ser239 are important for withanolide inhibitor recognition via hydrogen bonding mechanisms.
Article
Full-text available
Most life science processes involve, at the atomic scale, recognition between two molecules. The prediction of such interactions at the molecular level, by so-called docking software, is a non-trivial task. Docking programs have a wide range of applications ranging from protein engineering to drug design. This article presents SwissDock, a web server dedicated to the docking of small molecules on target proteins. It is based on the EADock DSS engine, combined with setup scripts for curating common problems and for preparing both the target protein and the ligand input files. An efficient Ajax/HTML interface was designed and implemented so that scientists can easily submit dockings and retrieve the predicted complexes. For automated docking tasks, a programmatic SOAP interface has been set up and template programs can be downloaded in Perl, Python and PHP. The web site also provides an access to a database of manually curated complexes, based on the Ligand Protein Database. A wiki and a forum are available to the community to promote interactions between users. The SwissDock web site is available online at http://www.swissdock.ch. We believe it constitutes a step toward generalizing the use of docking tools beyond the traditional molecular modeling community.
Article
Full-text available
Molecular docking has become an increasingly important tool for drug discovery. In this review, we present a brief introduction of the available molecular docking methods, and their development and applications in drug discovery. The relevant basic theories, including sampling algorithms and scoring functions, are summarized. The differences in and performance of available docking software are also discussed. Flexible receptor molecular docking approaches, especially those including backbone flexibility in receptors, are a challenge for available docking methods. A recently developed Local Move Monte Carlo (LMMC) based approach is introduced as a potential solution to flexible receptor docking problems. Three application examples of molecular docking approaches for drug discovery are provided.
Article
Full-text available
Treatment of infectious diseases becomes more challenging with each passing year. This is especially true for infections caused by the opportunistic pathogen Pseudomonas aeruginosa, with its ability to rapidly develop resistance to multiple classes of antibiotics. Although the import of resistance mechanisms on mobile genetic elements is always a concern, the most difficult challenge we face with P. aeruginosa is its ability to rapidly develop resistance during the course of treating an infection. The chromosomally encoded AmpC cephalosporinase, the outer membrane porin OprD, and the multidrug efflux pumps are particularly relevant to this therapeutic challenge. The discussion presented in this review highlights the clinical significance of these chromosomally encoded resistance mechanisms, as well as the complex mechanisms/pathways by which P. aeruginosa regulates their expression. Although a great deal of knowledge has been gained toward understanding the regulation of AmpC, OprD, and efflux pumps in P. aeruginosa, it is clear that we have much to learn about how this resourceful pathogen coregulates different resistance mechanisms to overcome the antibacterial challenges it faces.
Article
Administration of an extract from the powdered root of the plant Withania somnifera was found to stimulate immunological activity in Babl/c mice. Treatment with five doses of Withania root extract (20 mg/dose/animal; i.p.) was found to enhance the total WBC count (17125 cells/mm(3)) on 10th day. Bone marrow cellularity (27x10(6) cells/femur) as well as alpha-esterase positive cell number (1800/4000 cells) also increased significantly (P<0.001) after the administration of Withania extract. Treatment with Withania extract along with the antigen (SRBC) produced an enhancement in the circulating antibody titre and the number of plaque forming cells (PFC) in the spleen. Maximum number of PFC (985 PFC/10(6) spleen cells) was obtained on the fourth day. Withania extract inhibited delayed type hypersentivity reaction in mice (Mantoux test). Administration of Withania extract also showed an enhancement in phagocytic activity of peritoneal macrophages (76.5 pigmented cells/200) when compared to control (31.5/200 cells) in mice. These results confirm the immunomodulatory activity of W. somnifera extract, which is a known immunomodulator in indigenous medicine.
Article
Pseudomonas aeruginosa continues to be a major cause of infections in Western society, in part because of its high intrinsic resistance to antibiotics. It has been demonstrated that this intrinsic resistance arises from the combination of unusually restricted outer-membrane permeability and secondary resistance mechanisms such as energy-dependent multidrug efflux and chromosomally encoded periplasmic beta-lactamase. Given this high level of natural resistance, mutational resistance to most classes of antibiotics can readily arise. In this review we summarize new insights into the mechanisms of resistance, and describe therapeutic approaches that can be used in the face of this continuing resistance threat, as well as new approaches that are being developed to combat resistance. Copyright 2000 Harcourt Publishers Ltd.
Article
Among the different biosynthetic pathways found in extant organisms, lysine biosynthesis is peculiar because it has two different anabolic routes. One is the diaminopimelic acid pathway (DAP), and the other over the a-aminoadipic acid route (AAA). A variant of the AAA route that includes some enzymes involved in arginine and leucine biosyntheses has been recently reported in Thermus thermophilus (Nishida et al. 1999). Here we describe the results of a detailed genomic analysis of each of the sequences involved in the two lysine anabolic routes, as well as of genes from other routes related to them. No evidence was found of an evolutionary relationship between the DAP and AAA enzymes. Our results suggest that the DAP pathway is related to arginine metabolism, since the lysC, asd, dapC, dapE, and lysA genes from lysine biosynthesis are related to the argB, argC, argD, argE, and speAC genes, respectively, whose products catalyze different steps in arginine metabolism. This work supports previous reports on the relationship between AAA gene products and some enzymes involved in leucine biosynthesis and the tricarboxylic acid cycle (Irvin and Bhattacharjee 1998; Miyazaki et al. 2001). Here we discuss the significance of the recent finding that several genes involved in the arginine (Arg) and leucine (Leu) biosynthesis participate in a new alternative route of the AAA pathway (Miyazaki et al. 2001). Our results demonstrate a clear relationship between the DAP and Arg routes, and between the AAA and Leu pathways.